Prevalence of diphtheria and tetanus antibodies and circulation of Corynebacterium diphtheriae in São Paulo, Brazil
- PMID: 17906776
- DOI: 10.1590/s0100-879x2006005000184
Prevalence of diphtheria and tetanus antibodies and circulation of Corynebacterium diphtheriae in São Paulo, Brazil
Abstract
The introduction of routine vaccination against tetanus and diphtheria in Brazil has decreased the incidence and changed the epidemiology of both diseases. We then investigated the prevalence of Corynebacterium diphtheriae carrier status and diphtheria and tetanus immunity in São Paulo, Brazil. From November 2001 to March 2003, 374 individuals were tested for the presence of C. diphtheriae in the naso-oropharynx and of serum diphtheria and tetanus antibodies. Participants were all healthy individuals without acute or chronic pathologies and they were stratified by age as follows: 0-12 months and 1-4, 5-9, 10-14, 15-24, 25-39, 40-59, and > or =60 years. Antibodies were assessed using a double-antigen ELISA. C. diphtheriae species were identified by biochemical analysis and toxigenicity was assessed by the Elek test. For diphtheria, full protection (antibodies > or =0.1 IU/mL) was present in 84% of the individuals, 15% had basic protection (antibodies > or =0.01 and <0.1 IU/mL) and 1% were susceptible (antibodies <0.01 IU/mL). Full tetanus protection (antibodies > or =0.1 IU/mL) was present in 79% of the participants, 18% had basic protection (antibodies > or =0.01 and <0.1 IU/mL) and 3% were susceptible (antibodies <0.01 IU/mL). The geometric mean of diphtheria and tetanus antibodies reached the highest values at 5-9 years and decreased until the 40-59-year age range, increasing again in individuals over 60 years. Three participants (0.8%) were carriers of C. diphtheriae, all non-toxigenic strains. The present results demonstrate the clear need of periodic booster for tetanus and diphtheria vaccine in adolescents and adults after primary immunization in childhood.
Similar articles
-
Antibody response to diphtheria-tetanus-pertussis immunization in preterm infants who receive dexamethasone for chronic lung disease.Pediatrics. 2004 Apr;113(4):733-7. doi: 10.1542/peds.113.4.733. Pediatrics. 2004. PMID: 15060220
-
Efficacy of diphtheria and tetanus vaccination in Gaza, Palestine.East Mediterr Health J. 2009 Mar-Apr;15(2):285-94. East Mediterr Health J. 2009. PMID: 19554974
-
Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.Hum Vaccin Immunother. 2014;10(10):2795-8. doi: 10.4161/21645515.2014.970494. Hum Vaccin Immunother. 2014. PMID: 25483640 Free PMC article.
-
Vaccination against diphtheria and tetanus. Assays, antigens, adjuvants and application.APMIS Suppl. 1998;81:1-40. APMIS Suppl. 1998. PMID: 9810281 Review. No abstract available.
-
Adjuvants for Clostridium tetani and Clostridium diphtheriae vaccines updating.Hum Antibodies. 2017;25(1-2):23-29. doi: 10.3233/HAB-160302. Hum Antibodies. 2017. PMID: 27858706 Review.
Cited by
-
Global, regional, and national burden and attributable risk factors of neurological disorders: The Global Burden of Disease study 1990-2019.Front Public Health. 2022 Nov 29;10:952161. doi: 10.3389/fpubh.2022.952161. eCollection 2022. Front Public Health. 2022. PMID: 36523572 Free PMC article.
-
Seroprevalence against Diphtheria in Pregnant Women and Newborns in Colombia: New Arguments to Promote Maternal Immunization.Vaccines (Basel). 2022 Mar 17;10(3):458. doi: 10.3390/vaccines10030458. Vaccines (Basel). 2022. PMID: 35335090 Free PMC article.
-
Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.Lancet Neurol. 2017 Nov;16(11):877-897. doi: 10.1016/S1474-4422(17)30299-5. Epub 2017 Sep 17. Lancet Neurol. 2017. PMID: 28931491 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
